{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:53:47Z","timestamp":1791910427013,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jaut.2018.10.014","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T09:42:01Z","timestamp":1540546921000},"page":"24-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":167,"special_numbering":"C","title":["Prognosticating autoimmune encephalitis: A systematic review"],"prefix":"10.1016","volume":"96","author":[{"given":"James","family":"Broadley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udaya","family":"Seneviratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Beech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Buzzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Butzkueven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mastura","family":"Monif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2018.10.014_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2217\/fnl.10.74","article-title":"Autoimmune limbic encephalitis","volume":"6","author":"Didelot","year":"2011","journal-title":"Future Neurol."},{"key":"10.1016\/j.jaut.2018.10.014_bib2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/jnnp.2006.100644","article-title":"Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes","volume":"78","author":"Bataller","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2018.10.014_bib3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2018.10.014_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.seizure.2017.05.017","article-title":"LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures","volume":"50","author":"Aurangzeb","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.jaut.2018.10.014_bib5","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.autneu.2015.08.002","article-title":"Cardiac sympathetic dysfunction in anti-NMDA receptor encephalitis","volume":"193","author":"Byun","year":"2015","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.jaut.2018.10.014_bib6","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/j.1528-1167.2012.03723.x","article-title":"The prognosis of idiopathic generalized epilepsy","volume":"53","author":"Seneviratne","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaut.2018.10.014_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.jaut.2018.10.014_bib8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2018.10.014_bib9","article-title":"Variations of movement disorders in anti-N-methyl-D-aspartate receptor encephalitis: a nationwide study in Taiwan","volume":"95","author":"Duan","year":"2016","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2018.10.014_bib10","author":"Wells G"},{"key":"10.1016\/j.jaut.2018.10.014_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1471-2458-13-154","article-title":"Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review","volume":"13","author":"Herzog","year":"2013","journal-title":"BMC Publ. Health"},{"key":"10.1016\/j.jaut.2018.10.014_bib12","series-title":"Development of a Quality Appraisal Tool for Case Series Studies Using a Modi\ufb01ed Delphi Technique","author":"Moga","year":"2012"},{"key":"10.1016\/j.jaut.2018.10.014_bib13","series-title":"Prognosis in Autoimmune Encephalitis: Database, Data in Brief","author":"Broadley","year":"2018"},{"key":"10.1016\/j.jaut.2018.10.014_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.seizure.2015.04.005","article-title":"CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis","volume":"29","author":"Wang","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.jaut.2018.10.014_bib15","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.clinph.2017.04.015","article-title":"Analysis of electroencephalogram characteristics of anti-NMDA receptor encephalitis patients in China","volume":"128","author":"Zhang","year":"2017","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jaut.2018.10.014_bib16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2018.10.014_bib17","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/brain\/awt212","article-title":"Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype","volume":"136","author":"Irani","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2018.10.014_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146455","article-title":"Effect of immunotherapy on seizure outcome in patients with autoimmune encephalitis: a prospective observational registry study","volume":"11","author":"Byun","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2018.10.014_bib19","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/ane.12723","article-title":"Risk factors for mortality in patients with anti-NMDA receptor encephalitis","volume":"136","author":"Chi","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jaut.2018.10.014_bib20","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/brain\/awh203","article-title":"Clinical analysis of anti-Ma2-associated encephalitis","volume":"127","author":"Dalmau","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2018.10.014_bib21","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jclinepi.2006.02.005","article-title":"Prognosis research: why is Dr. Lydgate still waiting?","volume":"59","author":"Hemingway","year":"2006","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jaut.2018.10.014_bib22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1164\/rccm.201603-0507OC","article-title":"Anti-N-Methyl-d-Aspartate receptor encephalitis in adult patients requiring intensive care","volume":"195","author":"de Montmollin","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2018.10.014_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/ane.12575","article-title":"Suspected antibody negative autoimmune limbic encephalitis: outcome of immunotherapy","volume":"135","author":"von Rhein","year":"2017","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jaut.2018.10.014_bib24","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/ene.12911","article-title":"Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in southwest China","volume":"23","author":"Wang","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jaut.2018.10.014_bib25","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/01616412.2017.1351062","article-title":"Encephalitis with antibodies against the GABAB receptor: seizures as the most common presentation at admission","volume":"39","author":"Chen","year":"2017","journal-title":"Neurol. Res."},{"key":"10.1016\/j.jaut.2018.10.014_bib26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/ane.12556","article-title":"Initial serum thyroid peroxidase antibodies and long-term outcomes in SREAT","volume":"134","author":"Litmeier","year":"2016","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.jaut.2018.10.014_bib27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/brain\/awx323","article-title":"The importance of early immunotherapy in patients with faciobrachial dystonic seizures","volume":"141","author":"Thompson","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2018.10.014_bib28","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/epi.13797","article-title":"Predictive models in the diagnosis and treatment of autoimmune epilepsy","volume":"58","author":"Dubey","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.jaut.2018.10.014_bib29","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","article-title":"Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study","volume":"13","author":"Lee","year":"2016","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jaut.2018.10.014_bib30","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3389\/fimmu.2017.00835","article-title":"Risk factors for intensive care unit admission in patients with autoimmune encephalitis","volume":"8","author":"Harutyunyan","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2018.10.014_bib31","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/ene.12942","article-title":"Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis","volume":"23","author":"Constantinescu","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jaut.2018.10.014_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.23577","article-title":"Morvan syndrome: clinical and serological observations in 29 cases","volume":"72","author":"Irani","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2018.10.014_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.seizure.2015.04.007","article-title":"Retrospective case series of the clinical features, management and outcomes of patients with autoimmune epilepsy","volume":"29","author":"Dubey","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.jaut.2018.10.014_bib34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jneuroim.2015.08.014","article-title":"The spectrum of autoimmune encephalopathies","volume":"287","author":"Dubey","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2018.10.014_bib35","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/WNL.0000000000002635","article-title":"Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort","volume":"86","author":"Lee","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2018.10.014_bib36","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/WNL.0b013e31822cfc6b","article-title":"Analysis of relapses in anti-NMDAR encephalitis","volume":"77","author":"Gabilondo","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2018.10.014_bib37","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2018.10.014_bib38","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1038\/s41598-018-19490-z","article-title":"High albumin level is a predictor of favorable response to immunotherapy in autoimmune encephalitis","volume":"8","author":"Jang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2018.10.014_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3988\/jcn.2014.10.2.157","article-title":"Anti-N-methyl-d-aspartate receptor encephalitis in Korea: clinical features, treatment, and outcome","volume":"10","author":"Lim","year":"2014","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.jaut.2018.10.014_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Diagnosis and significance of antibody titres in anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2018.10.014_bib41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/jnnp-2013-306724","article-title":"Persistent anterograde amnesia following limbic encephalitis associated with antibodies to the voltage-gated potassium channel complex","volume":"85","author":"Butler","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jaut.2018.10.014_bib42","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.biopsych.2015.02.024","article-title":"Structural hippocampal damage following anti-N-Methyl-D-Aspartate receptor encephalitis","volume":"79","author":"Finke","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jaut.2018.10.014_bib43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","article-title":"Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies","volume":"74","author":"Finke","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jaut.2018.10.014_bib44","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1-associated cognitive impairment: presentation and long-term outcome","volume":"87","author":"Arino","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2018.10.014_bib45","doi-asserted-by":"crossref","first-page":"881","DOI":"10.4065\/mcp.2010.0326","article-title":"Autoimmune dementia: clinical course and predictors of immunotherapy response","volume":"85","author":"Flanagan","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jaut.2018.10.014_bib46","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1212\/WNL.0000000000000383","article-title":"Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsy","volume":"82","author":"Toledano","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2018.10.014_bib47","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamaneurol.2016.0232","article-title":"Association of progressive cerebellar atrophy with long-term outcome in patients with anti-N-Methyl-d-Aspartate receptor encephalitis","volume":"73","author":"Iizuka","year":"2016","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jaut.2018.10.014_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2018.10.014_bib49","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jaut.2018.10.014_bib50","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/archneurol.2011.2985","article-title":"Autoimmune epilepsy: clinical characteristics and response to immunotherapy","volume":"69","author":"Quek","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jaut.2018.10.014_bib51","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1212\/WNL.0b013e3182a4a49c","article-title":"Late-onset anti-NMDA receptor encephalitis","volume":"81","author":"Titulaer","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2018.10.014_bib52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2013.10.005","article-title":"VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy","volume":"265","author":"Shin","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jaut.2018.10.014_bib53","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jamaneurol.2014.2956","article-title":"Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment response","volume":"72","author":"Leypoldt","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jaut.2018.10.014_bib54","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","article-title":"Antibodies and neuronal autoimmune disorders of the CNS","volume":"257","author":"Graus","year":"2010","journal-title":"J. Neurol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118304876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841118304876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:19:59Z","timestamp":1760257199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841118304876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":54,"alternative-id":["S0896841118304876"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2018.10.014","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognosticating autoimmune encephalitis: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2018.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}